Mahoney Named Permanent Chair of UC's Department of Radiology
Mary Mahoney, MD, has been appointed chair of the Department of Radiology, effective Tuesday, Feb. 2. Mahoneys appointment as chair and Ben Felson Endowed Chair of Radiology was approved by the UC Board of Trustees. She also will serve as Chief of Imaging Services at UC Health.
Mahoney has served as interim chair since August 2014 as well as being a professor in the department and the Eugene L. and Sue R. Saenger Chair of Radiological Services. She joined the UC faculty in 1989 after completing her medical training at the UC College of Medicine and residencies and fellowship at UC Medical Center.
"Im honored and eager to continue in this leadership role, says Mahoney. "My goals are to strengthen the already impressive educational, research and clinical missions within the department while supporting my faculty and relationships with colleagues to support multidisciplinary possibilities within the college and the university at large.
A board-certified radiologist at UC Health, Mahoney is also the director for the Breast Imaging Fellowship at UC Medical Center. She belongs to a number of professional organizations including the Alpha Omega Alpha Society, the American College of Radiology and the Society of Chairs of Academic Radiology Departments, among others. She is also on the Board of Governors for the American Board of Radiology and is on the Board of Directors for the Radiological Society of North America.
She participates in the Executive Leadership in Academic Medicine (ELAM) Program for Women, and as vice chair of research for the department, she has been the institutional principal investigator for many research initiatives that focus on imaging within the college. Mahoney has also been instrumental in building the multidisciplinary breast center within the UC Cancer Institute.
Mary Mahoney, MD, reviews a digital mammogram.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.